LLY

1,004

-0.33%↓

JNJ

226.76

-1.74%↓

ABBV

210.42

-0.19%↓

UNH

393.66

-1.34%↓

AZN

181.62

-1.79%↓

LLY

1,004

-0.33%↓

JNJ

226.76

-1.74%↓

ABBV

210.42

-0.19%↓

UNH

393.66

-1.34%↓

AZN

181.62

-1.79%↓

LLY

1,004

-0.33%↓

JNJ

226.76

-1.74%↓

ABBV

210.42

-0.19%↓

UNH

393.66

-1.34%↓

AZN

181.62

-1.79%↓

LLY

1,004

-0.33%↓

JNJ

226.76

-1.74%↓

ABBV

210.42

-0.19%↓

UNH

393.66

-1.34%↓

AZN

181.62

-1.79%↓

LLY

1,004

-0.33%↓

JNJ

226.76

-1.74%↓

ABBV

210.42

-0.19%↓

UNH

393.66

-1.34%↓

AZN

181.62

-1.79%↓

Начало・Списък с акции・Pacira Pharmaceuticals Inc-DE

Pacira Pharmaceuticals Inc-DE

Затворен

СекторЗдравеопазване

22.63 -3.78

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

22.37

Максимум

23.8

Ключови измерители
By Trading Economics
Приходи	1.3M 2.9M
Продажби	-19M 177M
P/E Средно за сектора	174.923 51.415
EPS	0.6
Марж на печалбата	1.644
Служители	825
EBITDA	5M 30M

Препоръки
By TipRanks
Препоръки	Купи
12-месечна прогноза	+20.7% upside

Дивиденти
By Dow Jones
Следващи печалби	4.08.2026 г.

Пазарни показатели
By TradingEconomics
Пазарна капитализация	-204M 895M
Предишно отваряне	26.41
Предишно затваряне	22.63

Настроения в новините

By Acuity

50%

155 / 345 Класиране в Healthcare

Техническа оценка

By Trading Central

Увереност

Very Strong Bearish Evidence

24.83 / 26.38 Подкрепа & съпротива

Pacira Pharmaceuticals Inc-DE Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

15.05.2026 г., 22:47 ч. UTC

Горещи акции

Stocks to Watch: Macy's, Delta, UnitedHealth, NextNRG

15.05.2026 г., 22:16 ч. UTC

Придобивния, сливания и поглъщания

Canadian Tribunal Gives Keyera, Plains Until Late June to Rebut Bid to Undo Merger

15.05.2026 г., 22:00 ч. UTC

Значими двигатели на пазара

Delta Air Shares Rise as Berkshire Hathaway Discloses Stake

15.05.2026 г., 18:09 ч. UTC

Значими двигатели на пазара

Palo Alto Shares Head for Record-High Close, Analysts See Benefits to Identity Security Pivot

15.05.2026 г., 16:02 ч. UTC

Печалби

Значими двигатели на пазара

Forward Industries Shares Fall on New Debt as Solana Value Drops

15.05.2026 г., 14:55 ч. UTC

Значими двигатели на пазара

Aardvark Therapeutics Shares Plunge After FDA Hold on ARD-101 New Drug Application

15.05.2026 г., 14:43 ч. UTC

Значими двигатели на пазара

Chip Stocks Slide After U.S.-China Summit Ends Without Major Tech Deals -- Update

15.05.2026 г., 22:17 ч. UTC

Придобивния, сливания и поглъщания

Berkshire Boosted Stake in Alphabet in First Quarter, Bought Delta Air, Sold Visa, Mastercard -- Barrons.com

15.05.2026 г., 21:59 ч. UTC

Придобивния, сливания и поглъщания

Stanley Druckenmiller Just Exited Alphabet. TCI Fund Management Is Buying. -- Barrons.com

15.05.2026 г., 21:50 ч. UTC

Придобивния, сливания и поглъщания

Berkshire Boosted Stake in Alphabet in First Quarter, Bought Delta Air, Sold Visa, Mastercard -- Barrons.com

15.05.2026 г., 21:30 ч. UTC

Придобивния, сливания и поглъщания

Bill Ackman's Pershing Square Bets on Microsoft's AI Ambitions With New Stake -- 4th Update

15.05.2026 г., 21:16 ч. UTC

Пазарно говорене

Canada Oil Producers Expect Govt Cash Before Building Pathways Project -- Market Talk

15.05.2026 г., 20:50 ч. UTC

Пазарно говорене

Auto & Transport Roundup: Market Talk

15.05.2026 г., 20:50 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

15.05.2026 г., 20:19 ч. UTC

Горещи акции

Stocks to Watch Recap: Intel, Nvidia, Amgen, LVMH -- WSJ

15.05.2026 г., 19:41 ч. UTC

Придобивния, сливания и поглъщания

SanDisk Stock Is Up 494% This Year. Insiders Are Cashing In on the AI-Fueled Surge. -- Barrons.com

15.05.2026 г., 19:35 ч. UTC

Пазарно говорене

Oil Futures Settle Higher on Inventory Worries -- Market Talk

15.05.2026 г., 19:33 ч. UTC

Пазарно говорене

U.S. Natural Gas Futures Rise as Weather Heats Up -- Market Talk

15.05.2026 г., 18:35 ч. UTC

Печалби

Xanadu Quantum Revenue Increases Fourfold. Why the Stock Is Falling. -- Barrons.com

15.05.2026 г., 17:28 ч. UTC

Пазарно говорене

U.S. Oil Rig Count Rises by 5 to 415 -- Market Talk

15.05.2026 г., 16:50 ч. UTC

Придобивния, сливания и поглъщания

Microsoft Stock Moves Higher After Ackman Announces New Stake -- WSJ

15.05.2026 г., 16:24 ч. UTC

Придобивния, сливания и поглъщания

Bill Ackman's Pershing Square Bets on Microsoft's AI Ambitions With New Stake -- 3rd Update

15.05.2026 г., 16:20 ч. UTC

Пазарно говорене

Tech, Media & Telecom Roundup: Market Talk

15.05.2026 г., 16:20 ч. UTC

Пазарно говорене

Auto & Transport Roundup: Market Talk

15.05.2026 г., 16:20 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

15.05.2026 г., 15:55 ч. UTC

Пазарно говорене

Canada's 1Q Rebound Not a Turning Point -- Market Talk

15.05.2026 г., 15:20 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

15.05.2026 г., 15:20 ч. UTC

Пазарно говорене

Silver Plunges on Inflation Worries -- Market Talk

15.05.2026 г., 15:20 ч. UTC

Печалби

A Micron and Sandisk Peer Is Coming to U.S. Markets. What to Know About Japan's Kioxia. -- Barrons.com

15.05.2026 г., 14:33 ч. UTC

Пазарно говорене

Dollar Could Drift Higher as it Retains High-Yielding Status -- Market Talk

Сравнение с други в отрасъла

Ценова промяна

Pacira Pharmaceuticals Inc-DE Прогноза

Ценова цел

By TipRanks

20.7% нагоре

12-месечна прогноза

Среден 28.4 USD 20.7%

Висок 38 USD

Нисък 23 USD

Според 6 анализатори от Wall Street, предложили 12-месечна ценова цел за Pacira Pharmaceuticals Inc-DE през последните три месеца.

Консенсусна оценка

By TipRanks

Купи

6 ratings

Купи

Задържане

Продай

Според 6 анализатори, дали борсови рейтинги на Pacira Pharmaceuticals Inc-DE през последните 3 месеца.

Техническа оценка

By Trading Central

24.83 / 26.38Подкрепа & съпротива

Recent bearish events outweigh bullish events.

All events are bullish.

Bullish events outweigh bearish events.

Настроение

By Acuity

155 / 345 Класиране в Здравеопазване

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно Pacira Pharmaceuticals Inc-DE

Pacira BioSciences, Inc. engages in the development, manufacture, marketing, distribution, and sale of non-opioid pain management and regenerative health solutions to healthcare practitioners in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid handheld cryoanalgesia device used to produce controlled doses of cold temperature to targeted nerves. It has a development and commercialization, and supply agreement with Aratana Therapeutics, Inc. for NOCITA, a bupivacaine liposome injectable suspension product. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was incorporated in 2006 and is headquartered in Tampa, Florida.